| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 9 567-576, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
T Redmond, BK Brott, R Jove and MJ Welsh
Department of Anatomy and Cell Biology, University of Michigan Medical School, Ann Arbor 48109.
Previous studies have shown that the viral oncogene product, v-Src, is localized to a perinuclear structure. Here, we demonstrate by immunofluorescence analysis that the perinuclear structure corresponds to a local concentration of vesicles. Overexpressed normal cellular Src, c-Src, and a temperature-sensitive mutant of v-Src also are associated with these perinuclear vesicles. This perinuclear localization is observed in a variety of cell types using several different antibodies to Src, and it is independent of the fixation method. Immunoelectron ultracryomicroscopic analysis of rat fibroblast cells transformed by v-Src demonstrates an association of this protein with the limiting membranes of vesicles concentrated in the perinuclear region. These vesicles appear at the electron microscopic level to be multivesicular bodies on the basis of their size (0.3-1.0 microns in diameter), large electron-transparent lumens, and electron-dense vesicular inclusions. Morphometric analysis indicates that approximately 20% of the total cell v-Src protein is associated with these structures. This subpopulation of v-Src may have been recovered from the plasma membrane via the endocytotic pathway in a manner analogous to endocytosis of the epidermal growth factor receptor. Localization of the Src tyrosine kinases to these perinuclear endocytotic vesicles may be necessary for oncogenic transformation by v-Src and for normal functions of c-Src.
This article has been cited by other articles:
![]() |
V. G. Walker, A. Ammer, Z. Cao, A. C. Clump, B.-H. Jiang, L. C. Kelley, S. A. Weed, H. Zot, and D. C. Flynn PI3K activation is required for PMA-directed activation of cSrc by AFAP-110 Am J Physiol Cell Physiol, July 1, 2007; 293(1): C119 - C132. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gatesman, V. G. Walker, J. M. Baisden, S. A. Weed, and D. C. Flynn Protein Kinase C{alpha} Activates c-Src and Induces Podosome Formation via AFAP-110 Mol. Cell. Biol., September 1, 2004; 24(17): 7578 - 7597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamamoto, T. Maruyama, N. Sakai, R. Sakurai, A. Shimizu, T. Hamatani, H. Masuda, H. Uchida, H. Sabe, and Y. Yoshimura Expression and subcellular distribution of the active form of c-Src tyrosine kinase in differentiating human endometrial stromal cells Mol. Hum. Reprod., December 1, 2002; 8(12): 1117 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Korade-Mirnics and S. J. Corey Src kinase-mediated signaling in leukocytes J. Leukoc. Biol., November 1, 2000; 68(5): 603 - 613. [Abstract] [Full Text] |
||||
![]() |
M. T. Brown, J. Andrade, H. Radhakrishna, J. G. Donaldson, J. A. Cooper, and P. A. Randazzo ASAP1, a Phospholipid-Dependent Arf GTPase-Activating Protein That Associates with and Is Phosphorylated by Src Mol. Cell. Biol., December 1, 1998; 18(12): 7038 - 7051. [Abstract] [Full Text] |
||||
![]() |
K. Shimizu, H. Kawabe, S. Minami, T. Honda, K. Takaishi, H. Shirataki, and Y. Takai SMAP, an Smg GDS-associating Protein Having Arm Repeats and Phosphorylated by Src Tyrosine Kinase J. Biol. Chem., October 25, 1996; 271(43): 27013 - 27017. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Rebut-Bonneton, S Boutemy-Roulier, and D Evain-Brion Modulation of pp60c-src activity and cellular localization during differentiation of human trophoblast cells in culture J. Cell Sci., January 7, 1993; 105(3): 629 - 636. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |